PG
IBB icon

Proffitt & Goodson’s iShares Biotechnology ETF IBB Stock Holding History

Proffitt & Goodson’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Sell
6,119
-211
-3% -$36.3K 0.16% 53
2026
Q1 		$1.07M Sell
6,330
-27
-0.4% -$4.62K 0.16% 55
2025
Q4 		$1.07M Sell
6,357
-651
-9% -$106K 0.15% 59
2025
Q3 		$1.01M Sell
7,008
-62
-0.9% -$8.46K 0.15% 62
2025
Q2 		$894K Buy
7,070
+73
+1% +$8.96K 0.14% 67
2025
Q1 		$895K Buy
6,997
+51
+0.7% +$6.92K 0.15% 63
2024
Q4 		$918K Sell
6,946
-113
-2% -$15.9K 0.15% 66
2024
Q3 		$1.03M Sell
7,059
-27
-0.4% -$3.91K 0.17% 60
2024
Q2 		$973K Buy
7,086
+40
+0.6% +$5.34K 0.17% 60
2024
Q1 		$967K Sell
7,046
-72
-1% -$9.83K 0.17% 62
2023
Q4 		$967K Sell
7,118
-10
-0.1% -$1.22K 0.18% 60
2023
Q3 		$872K Buy
7,128
+23
+0.3% +$2.92K 0.18% 65
2023
Q2 		$902K Buy
7,105
+14
+0.2% +$1.82K 0.18% 61
2023
Q1 		$916K Sell
7,091
-1
-0% -$131 0.19% 61
2022
Q4 		$931K Buy
7,092
+54
+0.8% +$6.98K 0.2% 61
2022
Q3 		$823K Buy
7,038
+227
+3% +$28.2K 0.18% 63
2022
Q2 		$801K Buy
6,811
+26
+0.4% +$3.09K 0.16% 66
2022
Q1 		$884K Buy
6,785
+215
+3% +$28K 0.16% 66
2021
Q4 		$1M Sell
6,570
-72
-1% -$11.1K 0.18% 65
2021
Q3 		$1.07M Sell
6,642
-43
-0.6% -$7.24K 0.2% 52
2021
Q2 		$1.09M Sell
6,685
-874
-12% -$135K 0.2% 52
2021
Q1 		$1.14M Sell
7,559
-1,102
-13% -$175K 0.22% 52
2020
Q4 		$1.31M Sell
8,661
-445
-5% -$63.6K 0.27% 42
2020
Q3 		$1.23M Sell
9,106
-406
-4% -$55.1K 0.26% 38
2020
Q2 		$1.3M Sell
9,512
-275
-3% -$35.1K 0.29% 36
2020
Q1 		$1.05M Sell
9,787
-211
-2% -$24.3K 0.27% 37
2019
Q4 		$1.21M Buy
9,998
+410
+4% +$45.7K 0.27% 44
2019
Q3 		$954K Sell
9,588
-52
-0.5% -$5.44K 0.23% 50
2019
Q2 		$1.05M Hold
9,640
– – 0.26% 45
2019
Q1 		$1.08M Buy
9,640
+89
+0.9% +$9.76K 0.27% 43
2018
Q4 		$921K Sell
9,551
-118
-1% -$12.5K 0.26% 48
2018
Q3 		$1.18M Sell
9,669
-566
-6% -$66.7K 0.3% 39
2018
Q2 		$1.12M Sell
10,235
-987
-9% -$106K 0.48% 25
2018
Q1 		$1.2M Sell
11,222
-569
-5% -$63.1K 0.51% 25
2017
Q4 		$1.26M Sell
11,791
-128
-1% -$13.7K 0.52% 26
2017
Q3 		$1.32M Sell
11,919
-636
-5% -$68K 0.58% 20
2017
Q2 		$1.3M Sell
12,555
-1,059
-8% -$104K 0.58% 24
2017
Q1 		$1.33M Sell
13,614
-276
-2% -$26.4K 0.62% 27
2016
Q4 		$1.23M Buy
13,890
+78
+0.6% +$7.1K 0.62% 32
2016
Q3 		$1.33M Buy
13,812
+405
+3% +$38.5K 0.69% 22
2016
Q2 		$1.15M Sell
13,407
-153
-1% -$13.7K 0.63% 30
2016
Q1 		$1.18M Buy
+13,560
New +$1.21M 0.67% 30

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Proffitt & Goodson's IBB Position: Q2 2026 in Review

Proffitt & Goodson reduced its iShares Biotechnology ETF (IBB) stake by 3.3% in Q2 2026, selling an estimated $36.3K and leaving 6,119 shares worth $1.16M. The position accounts for 0.16% of the portfolio, ranked #53.

Proffitt & Goodson first reported a position in IBB in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.33M in Q3 2016. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Proffitt & Goodson held 6,119 shares of iShares Biotechnology ETF worth $1.16M as of Q2 2026.
  • Proffitt & Goodson sold 211 iShares Biotechnology ETF shares in Q2 2026, an estimated $36.3K.
  • iShares Biotechnology ETF made up 0.16% of Proffitt & Goodson's portfolio in Q2 2026, its #53 holding.
  • Proffitt & Goodson first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 42 quarters since.
  • Proffitt & Goodson's iShares Biotechnology ETF position peaked at $1.33M in Q3 2016.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.